InsiderTrades

Form 4 for HRTX HERON THERAPEUTICS, INC. /DE/

Accepted 2026-06-08 10:27:48 ET · period of report 2026-06-06 · accession 0001193125-26-260931 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-06-08 10:27 2026-06-06 HRTX Forbes William P EVP, Chief Development Off M - OptEx — +12.5K 221.6K +6% —
D 2026-06-08 10:27 2026-06-06 HRTX Forbes William P EVP, Chief Development Off M - OptEx $0.00 -12.5K 12.5K -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-06-06 M A 12,500 — 221,611 D — — (F1) Each restricted stock unit represents a contingent right to receive one share of common stock.
2 Derivative Restricted Stock Units 2026-06-06 M D 12,500 $0.00 12,500 D $0.00 · — to — 12,500 Common Stock (F2) The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date. (F2) The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date.